Former Chief Executive Officer of AHAC · Humacyte, Inc. (HUMA)

Rajiv Shukla

FY2021 is the first fiscal year CompBrief holds for Rajiv Shukla as a named executive officer of Humacyte; the record below is that year, complete. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2021

$115,414

Salary $0Stock awards $0

4th of 4 named executive officers at Humacyte by FY2021 total.

4 named officers on file for Humacyte, FY2021

Rajiv Shukla’s pay file — $29

  • 1 fiscal year of pay, line by line
  • 1 equity grant, each cited to its filing
  • HUMA’s disclosed peer group of 18 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how Humacyte’s whole pay program stands against its peers

  • Humacyte’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on HUMA→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 29, 2022 (DEF 14A). Insider transactions since that proxy, current to 2026-11-21.

Free

Get Rajiv Shukla’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Rajiv Shukla compensation by year

Humacyte Summary Compensation Table · the one fiscal year held
In US dollars, as Humacyte reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2021
Salary$0
Bonus$0
Stock awards$0
Option awards$98,159
Non-equity incentive$0
Pension and deferred compensation$0
All other$17,255
Total$115,414

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Humacyte, Inc. DEF 14A filed April 29, 2022, accession 0001818382-22-000028, and prior-year filings.

How this page was built: the Humacyte, Inc. filed document, accession 0001818382-22-000028. Every figure is read from that document and cited to the page and table it appears in. Filed April 29, 2022.

Equity holdings

unvested awards at FY2021 year-end
TypeUnvested unitsValue at year-endExercise price
Option13,000—$10.03

Per the Outstanding Equity Awards at Fiscal Year-End table in Humacyte, Inc.'s FY2021 proxy; value at the fiscal year-end close, as the company printed it.

Insider transactions since the last proxy

1 Form 4 line since the FY2021 proxy (filed April 29, 2022)
current to 2026-11-21 · updated nightly
DateTransactionPlanSharesPriceHeld after
2023-06-15Grant or award derivative—8,500$0.008,500

The 1 most recent of 1 lines, each as reported on the Form 4. "10b5-1" marks a trade the filing reports under a pre-arranged trading plan. View every Form 4 filing on EDGAR →

Humacyte’s named executive officers, FY2021

as the company reported each
Named executive officerRoleFY2021 total
Laura NiklasonPresident and Chief Executive Officer$10,804,789
Jeffrey LawsonFormer Chief Surgical Officer$907,000
Heather PrichardChief Operating Officer$576,436
Rajiv Shukla · this pageFormer Chief Executive Officer of AHAC$115,414

Board service

Humacyte board · FY2022–FY2024
Director compensation in US dollars, as Humacyte reports it. Most recent year first; a dash means the company reported no figure in that column.
Fiscal yearCash feesStock awardsOption awardsOtherTotal
FY2024$22,390—$0—$22,390
FY2023$50,000—$21,760—$71,760
FY2022$50,000—$27,995—$77,995

Each year as the company reported it in Humacyte's director compensation table. Totals are the company's own disclosed totals.

How this board is paid

Company policy: Humacyte pays directors a $50,000 cash retainer and $152,800 in equity. As stated in Humacyte's FY2025 proxy.

The full Humacyte compensation record

free company brief

This page is one person within Humacyte's record. The company brief lists every named executive, each linking to their own page.

Peer companies

named in the Humacyte proxy · each links to its own free brief

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Humacyte's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Rajiv Shukla's compensation dossier · One-time report. No refunds.